SIX reported a marked rise in listings, capital raising and trading activity across its Swiss and Spanish exmodifys in 2025, alongside record highs for the SMI and IBEX 35 benchmarks.
The Swiss Market Index crossed 13,000 points for the first time in February, closing the year at 13,267.5, up 14.4%. Spain’s IBEX 35 finished 2025 at 17,308, a 49.3% annual rise after breaching 17,000 points in December.
Trading turnover across both markets increased 15.5% year on year to CHF 1.63 trillion. Turnover on SIX Swiss Exmodify rose 12.8% to CHF 1.14 trillion, while the Swiss ETF segment grew 47.6% to CHF 124.3 billion, nearing its 2019 record. BME Exmodify turnover climbed 24.3% to €525.3 billion, led by a 34.1% increase in repaired income.
SIX recorded nearly 85 million transactions during the year, an 8.9% increase, with Swiss ETF trades reaching a record 3.37 million. Spain saw strong growth in securitised derivatives, up 32.5%.
Twenty companies listed across the two exmodifys, including Swiss IPOs from BioVersys, Amrize and SMG Swiss Marketplace Group. BioVersys and SMG toobtainher raised over CHF 1 billion, while Swiss companies raised CHF 2.7 billion via capital increases. In Spain, listed companies raised €10.9 billion, almost 80% more than in 2024.
SIX also reported record activity in structured products, with 169,099 listings in Switzerland, and continued expansion in ETFs and ETPs.
Gregor Braun, Head of Cash Market Sales, stated 2025 had been “a very successful year” and that SIX is well positioned “to shape the future of capital markets toobtainher.”
Leave a Reply